ARKEMA S/ADR - ARKAY STOCK NEWS

The annual general meeting of Arkema shareholders took place on 19 May 2022 in Paris, achieving a 77.90% quorum. Key resolutions included the approval of 2021 financial statements, a €3 dividend per share payable from 25 May 2022, and reaffirmations of board members. The Group also emphasized strong financial results for 2021, ongoing focus on Specialty Materials, and plans for innovative sustainable products. Arkema aims to become a leader in Specialty Materials by 2024, with 85.5% of 2021 sales coming from this sector.

Arkema has reported its shareholding structure as of April 30, 2022. The total number of shares stands at 74,286,041, with a total of 85,384,987 voting rights, including shares held by the company. Excluding those shares, the total number of voting rights is 85,052,243. This disclosure reflects the company's current equity landscape, essential for investors to understand their voting power and influence within the company.

Arkema reported strong financial results for Q1 2022, with sales of €2.9 billion, a 30% year-on-year increase at constant currency. EBITDA surged by 72.9% to €619 million, driven by high-performance materials and effective price adjustments amid rising raw material costs. The Group's adjusted net income rose to €376 million, or €4.96 per share, a 136.5% jump. While there were slight volume declines due to logistics issues, specialty materials now represent 90% of sales. Despite uncertainties, Arkema aims for continued growth and increased EBITDA for 2022.

Arkema invites its shareholders to the annual general meeting on May 19, 2022, at 10 a.m. in Paris. Key documents, including the preliminary notice, are accessible on Arkema's investor relations website. The company is focusing on becoming a leader in Specialty Materials by 2024, with a portfolio generating approximately €9.5 billion in sales in 2021. Arkema operates in 55 countries and employs about 20,200 staff, emphasizing innovation in materials science for sustainable solutions.

ARKEMA has announced key shareholder information as of March 31, 2022. The total number of shares stands at 74,286,041, while the total voting rights, including shares held by the company, is 85,032,465. Excluding shares held by the company, the total voting rights amount to 84,683,347. This update is critical for investors and stakeholders to understand voting power dynamics within the company.

Arkema has announced the publication of its 2021 Universal Registration Document, filed on 29 March 2022 with the French Markets Authority (AMF). The document is publicly available at Arkema's website. It includes the Annual Financial Report, Corporate Governance Report, and the Financial Statements for 2021. Arkema reported sales of approximately €9.5 billion in 2021 and aims to become a pure player in Specialty Materials by 2024, focusing on three segments: Adhesive Solutions, Advanced Materials, and Coating Solutions.

Arkema has announced share buyback transactions conducted between 07 March and 11 March 2022, in compliance with EU regulation. A total of 5,261 shares were repurchased at an average price of €96.08 per share. The transactions occurred on Euronext Paris under the ticker ARKAY. This strategic move may enhance shareholder value by reducing the number of shares outstanding, potentially increasing earnings per share in the future. The company's commitment to shareholder returns through buybacks is underscored by this action.

On February 28, 2022, Arkema reported its share and voting rights details. The total number of shares is 74,286,041, with a total of 85,054,281 voting rights, including those held by the company. Excluding shares held by the company, the voting rights total 84,725,163. This data may indicate shareholder engagement levels and overall ownership structure, which are crucial for investor assessments.

Arkema has executed share buyback transactions from February 28 to March 4, 2022, totaling 14,739 shares. The buybacks occurred on three separate days with varying share volumes: 4,739 shares at €113.0352 on March 2, 5,000 shares at €112.8145 on March 3, and 5,000 shares at €104.1590 on March 4. The overall weighted average purchase price was €109.9492. This move aligns with the company's strategy to enhance shareholder value and reflects a commitment to returning capital to investors.